Patents by Inventor Jorg Eibl
Jorg Eibl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20160031781Abstract: The invention concerns a pharmaceutical preparation which improves penetration of active substances through the tissue membrane or barrier of the target organ.Type: ApplicationFiled: August 3, 2015Publication date: February 4, 2016Applicant: Genzyme CorporationInventors: Hans-Jorg EIBL, Peter Hoffman
-
Patent number: 8497388Abstract: Phospholipid-analogous compounds of the general formula (I) in which a is b is where R1 and R2 are, independently of one another, hydrogen, a saturated or unsaturated acyl or alkyl radical which can optionally be branched or/and substituted, where the total of the carbon atoms in the acyl and alkyl is 16 to 44 C atoms, s is an integer from 0 to 8, c is a radical of a primary or secondary alcohol of the formula RO—, where R is a saturated or unsaturated alkyl radical, mainly with cis double bond, of froth 12 to 30 carbon atoms, n is an integer from 2 to 8, R3 a can be 1,2-dihydroxypropyl or b can be alkyl with 1 to 3 C atoms when z is >0 or c can be alkyl with 1 to 3 carbon atoms when n?2 and z=0, m is 1 or 2, x is an integer from 0 to 8, y is 1 for z=1 to 5 or is 1 to 4 for z=1 z is an integer from 0 to 5, are novel and are suitable as liposome constituents, solubilizers and pharmaceuticals.Type: GrantFiled: April 12, 2011Date of Patent: July 30, 2013Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften. e.V.Inventor: Hans-Jörg Eibl
-
Publication number: 20120172631Abstract: In order to form liposomes with a longer half-life in blood, use is made of defined compounds with the general formula (A)Type: ApplicationFiled: December 13, 2011Publication date: July 5, 2012Applicant: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e. V.Inventor: Hans-Jõrg EIBL
-
Publication number: 20120064147Abstract: The invention concerns a pharmaceutical preparation which improves penetration of active substances through the tissue membrane or barrier of the target organ.Type: ApplicationFiled: April 19, 2011Publication date: March 15, 2012Applicants: Genzyme Corporation, Max-Planck Gesellschaft Zur Foerderung Der Wissenshaften E.V.Inventors: Hans-Jorg EIBL, Peter Hoffmann
-
Publication number: 20120009246Abstract: Phospholipid-analogous compounds of the general formula (I) in which a is b is where R1 and R2 are, independently of one another, hydrogen, a saturated or unsaturated acyl or alkyl radical which can optionally be branched or/and substituted, where the total of the carbon atoms in the acyl and alkyl is 16 to 44 C atoms, s is an integer from 0 to 8, c is a radical of a primary or secondary alcohol of the formula RO—, where R is a saturated or unsaturated alkyl radical, mainly with cis double bond, of froth 12 to 30 carbon atoms, n is an integer from 2 to 8, R3 a can be 1,2-dihydroxypropyl or b can be alkyl with 1 to 3 C atoms when z is >0 or c can be alkyl with 1 to 3 carbon atoms when n?2 and z=0, m is 1 or 2, x is an integer from 0 to 8, y is 1 for z=1 to 5 or is 1 to 4 for z=1 z is an integer from 0 to 5, are novel and are suitable as liposome constituents, solubilizers and pharmaceuticals.Type: ApplicationFiled: April 12, 2011Publication date: January 12, 2012Applicant: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.Inventor: Hans-Jörg EIBL
-
Patent number: 8076520Abstract: In order to form liposomes with a longer half-life in blood, use is made of defined compounds with the general formula (A)Type: GrantFiled: March 31, 2010Date of Patent: December 13, 2011Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.Inventor: Hans-Jörg Eibl
-
Patent number: 7939683Abstract: Phospholipid-analogous compounds of the general formula (I) in which A is where R1 and R2 are, independently of one another, hydrogen, a saturated or unsaturated acyl or alkyl radical which can optionally be branched or/and substituted, where the total of the carbon atoms in the acyl and alkyl is 16 to 44 carbon atoms, s is an integer from 0 to 8, c is a radical of a primary or secondary alcohol of the formula RO—, where R is a saturated or unsaturated alkyl radical, mainly with cis double bond, of from 12 to 30 carbon atoms, n is an integer from 2 to 8, R3— a can be 1,2-dihydroxypropyl or b can be alkyl with 1 to 3 carbon atoms when z is >0 or c can be alkyl with 1 to 3 carbon atoms when n?2, and z=0, m is 1 or 2, x is an integer from 0 to 8, y is 1 for z=1 to 5 or is 1 to 4 for z=1, z is an integer from 0 to 5, are novel and are suitable as liposome constituents, solubilizers and pharmaceuticals.Type: GrantFiled: September 28, 2009Date of Patent: May 10, 2011Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.Inventor: Hans-Jörg Eibl
-
Publication number: 20100280282Abstract: In order to form liposomes with a longer half-life in blood, use is made of defined compounds with the general formula (A)Type: ApplicationFiled: March 31, 2010Publication date: November 4, 2010Applicant: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.Inventor: Hans-Jörg EIBL
-
Publication number: 20100183705Abstract: Phospholipid-analogous compounds of the general formula (I) in which A where R1 and R2 are, independently of one another, hydrogen, a saturated or unsaturated acyl or alkyl radical which can optionally be branched or/and substituted, where the total of the carbon atoms in the acyl and alkyl is 16 to 44 C atoms, s is an integer from 0 to 8, c is a radical of a primary or secondary alcohol of the formula RO—, where R is a saturated or unsaturated alkyl radical, mainly with cis double bond, of from 12 to 30 carbon atoms, n is an integer from 2 to 8, R3 a can be 1,2-dihydroxypropyl or b can be alkyl with 1 to 3 C atoms when z is >0 or c can be alkyl with 1 to 3 carbon atoms when n?2 and z=0, m is 1 or 2, x is an integer from 0 to 8, y is 1 for z=1 to S? or is 1 to 4 for z=1 z is an integer from 0 to 5, are novel and are suitable as liposome constituents, solubilizers and pharmaceuticals.Type: ApplicationFiled: September 28, 2009Publication date: July 22, 2010Applicant: Max-Planck-Gesellschaft zur Förderung du Wissenschaften e.V.Inventor: Hans-Jörg EIBL
-
Patent number: 7709464Abstract: In order to form liposomes with a longer half-life in blood, use is made of defined compounds with the general formula (A)Type: GrantFiled: March 31, 2008Date of Patent: May 4, 2010Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e. V.Inventor: Hans-Jorg Eibl
-
Patent number: 7595411Abstract: The present invention relates to compositions comprising a water-insoluble pharmaceutically active ingredient or a substance having low water solubility, and a compound represented by Structural Formula (I): in which A is: The present invention further relates to methods of solubilizing substances of low water solubility, and methods of preparing compositions suitable for intravenous administration.Type: GrantFiled: October 21, 2004Date of Patent: September 29, 2009Assignee: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.V.Inventor: Hans-Jörg Eibl
-
Publication number: 20090035358Abstract: In order to form liposomes with a longer half-life in blood, use is made of defined compounds with the general formula (A)Type: ApplicationFiled: March 31, 2008Publication date: February 5, 2009Applicant: Max-Planck-Gesselschaft zur Forderung Der Wissenschaften E.V.Inventor: Hans-Jorg Eibl
-
Publication number: 20080090781Abstract: The invention relates to novel medicament formulations containing, as active ingredients, alkylphosphocholines and the like, alkyl-alkanediol-phosphocholines and the like, and (ether)lysolecithines and the like, in different forms of embodiment. Said active ingredients are integral constituents of liposomes, also containing cholesterol and the like and a negative charge carrier. The medicament formulations are especially suitable for the treatment and/or prophylaxis of cancer, protozoan diseases such as leishmaniasis and amoebic diseases, acariasis and diseases caused by arthropods, and bacterial diseases, such as ehrlichiosis. Ocular diseases accompanied by uncontrolled cellular processes can also be advantageously influenced.Type: ApplicationFiled: October 19, 2005Publication date: April 17, 2008Applicant: Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E.V.Inventors: Hans jörg Eibl, Susanne Christine Wieland-Berghausen, Jean Steffan
-
Patent number: 7351428Abstract: In order to form liposomes with a longer half-life in blood, use is made of defined formula (A)Type: GrantFiled: May 7, 2004Date of Patent: April 1, 2008Assignee: Max-Planck-Gesselschaft zur Forderung der Wissenschaften E.V.Inventor: Hans-Jörg Eibl
-
Publication number: 20050165245Abstract: The present invention relates to compositions comprising a water-insoluble pharmaceutically active ingredient or a substance having low water solubility, and a compound represented by Structural Formula (I): in which A is: The present invention further relates to methods of solubilizing substances of low water solubility, and methods of preparing compositions suitable for intravenous administration.Type: ApplicationFiled: October 21, 2004Publication date: July 28, 2005Applicant: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.Inventor: Hans-Jorg Eibl
-
Publication number: 20040247659Abstract: The present invention concerns new liposome preparations which contain (ester)-lysolecithin compounds. The liposomes are especially suitable for packaging active substances.Type: ApplicationFiled: March 29, 2004Publication date: December 9, 2004Inventor: Jorg Eibl
-
Patent number: 6828453Abstract: Phospholipid-analogous compounds of the general formula (I) in which A where R1 and R2 are, independently of one another, hydrogen, a saturated or unsaturated acyl or alkyl radical which can optionally be branched or/and substituted, where the total of the carbon atoms in the acyl and alkyl is 16 to 44 C atoms, s is an integer from 0 to 8, c is a radical of a primary or secondary alcohol of the formula RO—, where R is a saturated or unsaturated alkyl radical, mainly with cis double bond, of from 12 to 30 carbon atoms, n is an integer from 2 to 8, R3 a can be 1,2-dihydroxypropyl or b 5 can be alkyl with 1 to 3 C atoms when z is >0 or c can be alkyl with 1 to 3 carbon atoms when n≠2 and z=0, m is 1 or 2, x is an integer from 0 to 8, y 10 is 1 for z=1 to 5 or is 1 to 4 for z=1 z is an integer from 0 to 5, are novel and are suitable as liposome constituents, solubilizers and pharmaceuticals.Type: GrantFiled: March 4, 2003Date of Patent: December 7, 2004Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.VInventor: Hans-Jörg Eibl
-
Publication number: 20040213836Abstract: In order to form liposomes with a longer half-life in blood, use is made of defined formula (A) 1Type: ApplicationFiled: May 7, 2004Publication date: October 28, 2004Applicant: Max-Planck-Gesselschaft zur Forderung Der Wissenschaften E.V.Inventor: Hans-Jorg Eibl
-
Publication number: 20030198663Abstract: Phospholipid-analogous compounds of the general formula (I) 1Type: ApplicationFiled: March 4, 2003Publication date: October 23, 2003Inventor: Hans-Jorg Eibl
-
Patent number: 6545169Abstract: Phospholipid-analogous compounds of the general formula (I) in which A where R1 and R2 are, independently of one another, hydrogen, a saturated or unsaturated acyl or alkyl radical which can optionally be branched or/and substituted, where the total of the carbon atoms in the acyl and alkyl is 16 to 44 C atoms, s is an integer from 0 to 8, c is a radical of a primary or secondary alcohol of the formula RO—, where R is a saturated or unsaturated alkyl radical, mainly with cis double bond, of from 12 to 30 carbon atoms, n is an integer from 2 to 8, R3 a can be 1,2-dihydroxypropyl or b can be alkyl with 1 to 3 C atoms when z is>0 or c can be alkyl with 1 to 3 carbon atoms when n≠2 and z=0, m is 1 or 2, x is an integer from 0 to 8, y is 1 for z=1 to 5 or is 1 to 4 for z=1 z is an integer from 0 to 5, are novel and are suitable as liposome constituents, solubilizers and pharmaceuticals.Type: GrantFiled: December 26, 2001Date of Patent: April 8, 2003Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften e.V.Inventor: Hans-Jörg Eibl